Association of non-Alcoholic Fatty Liver Disease with Urolithiasis detected on non-Contrast Computed Tomography

Kamil Abdulmajeed  Ahmed; Saeed Nadhim Younis

doi:10.56056/amj.2022.183

Authors

Kamil Abdulmajeed Ahmed M.B.Ch.B, Department of Radiology, Rizgary Teaching Hospital, Erbil, Iraq
Saeed Nadhim Younis M.B.Ch.B, DMRD, PhD, Professor of Radiology, Kurdistan Higher council of Medical Specialties, Erbil, Iraq

DOI:

https://doi.org/10.56056/amj.2022.183

Keywords:

Non-alcoholic fatty liver disease, Urolithiasis, Non-contrast CT

Abstract

Background & Objectives: We aimed to assess whether there is an association between urolithiasis and non-alcoholic fatty liver disease using non-enhanced computed tomography.

Methods :This is a case control study done from October to December 2019, a total of 284 non-contrasts CT scans of reviewed. The subjects were assigned in to cases of non-alcoholic fatty liver group defined with lower average Hounsfield unit of liver than that of spleen and control involved non-fatty liver defined as patients whose Hounsfield of liver parenchyma higher than that of spleen. We determined the percentage of urolithiasis (patients having radiopaque stones in the urinary tract including kidneys, ureters or urinary bladder) in both groups and calculated their significance of relation.

Results: The non-alcoholic fatty liver group involved 112 cases of which 67 (59.8%) male, 45 (40.2%) female and control of non-fatty liver group involved 172 cases; of which, 89 (51.8%) male, 83 (48.2%) female. The incidence of stone disease was significantly higher in non-alcoholic fatty liver (36.6%) than control group (12.2%) which statistically significant with increasing detection rate of renal stone (OR: 4.1, 95% CI, 2.28-7.54). The correlation was still significant when evaluated among males and females separately. Though the prevalence of stone among males (25.6%) is higher than females (17.2), yet it was not statistically significant. This is also true among males (41.8% stone) and females (28.9% stone) in case subjects.

Conclusion: Non-alcoholic fatty liver has an association with significant increase in prevalence of urolithiasis than those without non-alcoholic fatty liver, that is can be considered an independent risk factor variable for renal stone formation.

Downloads

Download data is not yet available.

References

Glen J, Floros L, Day C, et al. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance. BMJ 2016;354: i4428.

European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). OEASL-EASDEASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016; 64(6):1388–402.

Qin S, Wang S, Wang X et al. Non-alcoholic fatty liver disease and the risk of urolithiasis. A systematic review and meta-analysis. Medicine 2018; 97:35(e12092)

Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus,

cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol

; 10:330–44

Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67:328–57

Nam IC. Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography. Eur J Radiol Open.2016; 3 :195-9

Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015; 313:2263–73.

Adams LA, Anstee QM, Tilg H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017; 66:1138–53.

McPherson S, Hardy T, Henderson E, et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management. J Hepatol 2015; 62:1148–55

Ekstedt M, Hagström H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015; 61:1547–54.

Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015; 149:389–97. e10

Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol 2012; 62:160-5. doi: 10.1016/j.eururo.2012.03.052.

Einollahi B, Naghii MR, Sepandi M. Association of nonalcoholic fatty liver disease (NAFLD) with urolithiasis. Endocr Regul 2013; 47:27-32. doi:10.4149/endo_2013_01_27

Spatola L, Ferraro PM, Gambaro G, Badalamenti S, Dauriz M. Metabolic Syndrome and Uric Acid Nephrolithiasis: Insulin Resistance in Focus. Metabolism 2018; 83:225-33. doi: 10.1016/j.metabol.2018.02.008

Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005; 293:455-62. doi:10.1001/jama.293.4.455

Wei YP, Lin XG, He RQ, et al. Epidemiologic association of nonalcoholic fatty liver disease and urinary calculi: a population based cross-sectional study in Southern China. Iran J Kidney Dis 2018; 12:112–9.

Kim S, Chang Y, Sung E, et al. Non-alcoholic fatty liver disease and the development of nephrolithiasis: a cohort study. PloS One 2017;12: e0184506.

Tariq Z, Green CJ, Hodson L. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)? Liver Int 2014;34: e180–90.

Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol 2017; 13:509–20.

Abate N, Chandalia M, Cabo-Chan AV Jr. et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004; 65:386– 92. https://doi.org/10.1111/j.1523-1755.2004.00386.x PMID: 14717908

Guolin L, Wang S, Hui H, Yaqin C, Li L, Dazhong Y. Nonalcoholic fatty liver disease associated with impairment of kidney function in non-diabetes population. Biochemia Medica 2012;22(1):92–9

Zeina AR, Goldenberg L, Nachtigal A, et al. Association between nephrolithiasis and fatty liver detected on non-enhanced CT for clinically suspected renal colic. Clin Imaging 2017; 43:148–52.